DENTSPLY SIRONA Inc. (LON:0I8F)
16.56
+0.21 (1.28%)
At close: Jun 10, 2025
DENTSPLY SIRONA Revenue
DENTSPLY SIRONA had revenue of $879.00M USD in the quarter ending March 31, 2025, a decrease of -7.76%. This brings the company's revenue in the last twelve months to $3.72B, down -5.61% year-over-year. In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%.
Revenue (ttm)
$3.72B
Revenue Growth
-5.61%
P/S Ratio
0.80
Revenue / Employee
$265.64K
Employees
14,000
Market Cap
2.29B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
DENTSPLY SIRONA News
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect - Accesswire
- 6 days ago - INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY - Accesswire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation - Accesswire
- 9 days ago - Dentsply Sirona prices offering of $550M of junior subordinated notes - Seeking Alpha
- 9 days ago - Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes - GlobeNewsWire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation - Accesswire
- 10 days ago - Buying Dentsply Sirona - Seeking Alpha
- 12 days ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire